BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28347247)

  • 1. Decreased RNA-binding motif 5 expression is associated with tumor progression in gastric cancer.
    Kobayashi T; Ishida J; Shimizu Y; Kawakami H; Suda G; Muranaka T; Komatsu Y; Asaka M; Sakamoto N
    Tumour Biol; 2017 Mar; 39(3):1010428317694547. PubMed ID: 28347247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.
    Lin YL; Chen HL; Cheng SB; Yeh DC; Huang CC; P'eng FK; Tsai TC; Wu CC; Chen CM
    Int J Clin Exp Pathol; 2015; 8(11):14257-69. PubMed ID: 26823742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer.
    Saavedra K; Valbuena J; Olivares W; Marchant MJ; Rodríguez A; Torres-Estay V; Carrasco-Avino G; Guzmán L; Aguayo F; Roa JC; Corvalán AH
    PLoS One; 2015; 10(5):e0125834. PubMed ID: 25954972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
    Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF.
    Kong F; Deng X; Kong X; Du Y; Li L; Zhu H; Wang Y; Xie D; Guha S; Li Z; Guan M; Xie K
    Oncogene; 2018 Nov; 37(45):5982-5996. PubMed ID: 29985481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis.
    Bian Y; Wang L; Lu H; Yang G; Zhang Z; Fu H; Lu X; Wei M; Sun J; Zhao Q; Dong G; Lu Z
    Biochem Biophys Res Commun; 2012 May; 422(1):187-93. PubMed ID: 22569043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5.
    Kobayashi T; Ishida J; Musashi M; Ota S; Yoshida T; Shimizu Y; Chuma M; Kawakami H; Asaka M; Tanaka J; Imamura M; Kobayashi M; Itoh H; Edamatsu H; Sutherland LC; Brachmann RK
    Int J Cancer; 2011 Jan; 128(2):304-18. PubMed ID: 20309933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
    Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
    Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
    Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
    J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis.
    Oh JJ; Razfar A; Delgado I; Reed RA; Malkina A; Boctor B; Slamon DJ
    Cancer Res; 2006 Apr; 66(7):3419-27. PubMed ID: 16585163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BOP1 Silencing Suppresses Gastric Cancer Proliferation through p53 Modulation.
    Yang YP; Qin RH; Zhao JJ; Qin XY
    Curr Med Sci; 2021 Apr; 41(2):287-296. PubMed ID: 33877544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
    Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
    Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating RNA Binding Motif 5 Gene Expression- A Novel Therapeutic Target for Lung Cancer.
    Prabhu VV; Devaraj N
    J Environ Pathol Toxicol Oncol; 2017; 36(2):99-105. PubMed ID: 29199590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.
    Wang M; Chen L; Chen Y; Wei R; Guo Q; Zhu S; Guo S; Zhu S; Zhang S; Min L
    Mol Oncol; 2020 May; 14(5):1045-1058. PubMed ID: 32086862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDRG1 gene silencing contributes to inhibit the growth and induce apoptosis of gastric cancer cells.
    Zhang YJ; Li JQ; Li HZ; Song H; Wei CS; Zhang SQ
    Pathol Res Pract; 2019 Oct; 215(10):152567. PubMed ID: 31383535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells.
    Mukhopadhyay UK; Senderowicz AM; Ferbeyre G
    Cancer Res; 2005 Apr; 65(7):2872-81. PubMed ID: 15805289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells.
    Lim D; Jocelyn KM; Yip GW; Bay BH
    Cancer Lett; 2009 Apr; 276(1):109-17. PubMed ID: 19062161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.